A Delaware Superior Court Judge has allowed roughly 75,000 plaintiffs to be heard in Delaware courts regarding whether the drug Zantac caused cancer. This is a massive turn of events, as nearly 50,000 similar lawsuits were dismissed in federal courts just two years ago. In 2022, the federal judge in…
Articles Posted in Zantac carcinogen
Zantac Litigation Focused on Bladder, Liver, Esophageal, Gastric, and Pancreatic Cancers
In any product liability litigation, the injured person must ultimately prove that the injury was caused by the defective product (legal causation). A relatively easy example is when a lamp explodes and burns an individual, and in the post-explosion investigation the plaintiff discovers the lamp’s wiring was faulty and unreasonably…
Court Rulings in Zantac Litigation Could Toss Many Cases: What This Means for You
After news broke that Zantac (the brand name for ranitidine) was linked to cancer, a large wave of lawsuits started making their way into state and federal courts. Many of these cases have been consolidated into the Zantac multi-district litigation, or MDL 2924. The Zantac MDL is still in the…
Zantac Litigation Master Complaint Key Points, Part 1: The Parties Involved
If you truly want to learn about a particular litigation involving a defective product (such as Zantac), the best place to start is the Master Complaint. This is the lengthy comprehensive document filed by the plaintiffs in a multi-district litigation involving a defective product. This does not mean the case…
Zantac: Overview of Recall and Lawsuits Due to Cancer-Causing NDMA
Many of us suffer from heartburn, and one of the most popular ways to treat it is by taking Zantac. Until recently, Zantac was considered a very safe medication and was available without a prescription. Given how well it worked, along with its affordable price and the perception of safety,…